富士胶片助力中国首本上消化道早癌 BLI 病理对照图谱正式发布

2019-08-20 佚名 美通社

上海 2019 年 8 月 19 日 / 美通社 / -- 8 月 17 日,正值 2019 中国内镜医师大会期间,由海军军医大学附属长海医院(以下简称 “长海医院”)与富士胶片(中国)投资有限公司(以下简称“富士胶片(中国)”)共同举办的“消化道早癌新技术经验交流会暨《上消化道早癌蓝光成像与病理对照图谱》新书发布会” 在武汉顺利举行。

上海 2019 年 8 月 19 日 / 美通社 / -- 8 月 17 日,正值 2019 中国内镜医师大会期间,由海军军医大学附属长海医院(以下简称 “长海医院”)与富士胶片(中国)投资有限公司(以下简称“富士胶片(中国)”)共同举办的“消化道早癌新技术经验交流会暨《上消化道早癌蓝光成像与病理对照图谱》新书发布会” 在武汉顺利举行。

此次全新发布的《上消化道早癌蓝光成像与病理对照图谱》是中国第一本专门针对上消化道早癌蓝光成像与病理进行对照的图谱,将为中国内镜医师在上消化道早癌诊疗方面提供重要参考。

本书收集了 43 例上消化道早癌病例(其中食道癌 18 例,癌 25 例),通过 391 张高清内镜图片和 194 张病理复原图进行对照,具体展示了各型上消化道早癌的内镜特征。部分病例还分别根据世界卫生组织和日本标准给出不同的诊断,供内镜医生学习和参考。

我国是消化道癌症(癌、食道癌、肠癌等)的高发区,有统计数据显示,我国食管鳞癌和胃癌每年的新增病例和死亡病例约占世界的一半,大肠癌的发病率也在逐年升高。大多数消化道恶性肿瘤患者确诊时已处于进展期,施行有效的筛查和早诊早治是降低上消化道癌死亡率、提高生存率和生存质量的重要手段。

近年来,内镜设备技术不断发展,如蓝光成像技术(Blue Light Imaging, 简称 BLI)能够增强黏膜表层微血管和微结构的对比度,实现对细微血管或结构的观察,图像更清晰、更易于识别,无论在早癌筛查还是精查中都有较强的优势,对临床医生的诊断更有帮助,使得上消化道肿瘤的早诊早治成为可能。但是我国消化道早癌的诊治水平,尤其是上消化道早癌方面,与发达国家相比还存在一定差距。

为了给内镜医生、尤其是年轻内镜医生提供实例学习资料,将蓝光成像技术这项新的内镜诊疗技术更好地应用到临床工作中,李兆申院士发起《上消化道早癌蓝光成像与病理对照图谱》项目并担任主审,长海医院消化内镜中心副主任王东教授、消化内科副主任医师施新岗教授、病理科副主任医师高莉教授共同参与主编,完成了这本内容殷实、具有权威性的图谱。王东教授在发布会上提到,多位医师共同参与从收集整理病例、病理复原到一系列的对照、描述、点评,将有助于内镜医生积累经验,提高诊断技术。

富士胶片始终致力于为中国内镜事业做出一份应有的贡献,此次,搭载了 LCI 联动成像技术和 BLI 蓝光成像技术的富士胶片 LASEREO 内窥镜系统全程支持参与上消化道早癌蓝光成像与病理对照图谱,进行上消化道早癌的内镜精查和图像采集,就是该承诺的实践之一,期待这份图谱能帮助更多内镜医生提高自身的诊疗能力。

长海医院多名医师带来丰富学术课题及病理分享,现场学术气氛浓烈,学员各有收获。富士胶片(中国)将继续支持此类临床研究和学术分享活动,助力我国消化道早癌诊治水平的提升,促进中国健康事业发展。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1775471, encodeId=a3081e7547169, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Sat Oct 26 20:36:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723078, encodeId=56331e2307821, content=<a href='/topic/show?id=0cc01998259' target=_blank style='color:#2F92EE;'>#上消化道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19982, encryptionId=0cc01998259, topicName=上消化道)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b81833366357, createdName=zchen, createdTime=Sat Jan 11 23:36:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946557, encodeId=d365194655e9b, content=<a href='/topic/show?id=91c646562f6' target=_blank style='color:#2F92EE;'>#富士胶片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46562, encryptionId=91c646562f6, topicName=富士胶片)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Wed Feb 19 22:36:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799694, encodeId=1a231e9969490, content=<a href='/topic/show?id=85b9e10284e' target=_blank style='color:#2F92EE;'>#病理对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71028, encryptionId=85b9e10284e, topicName=病理对照)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Wed Aug 21 20:36:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464626, encodeId=3bad146462658, content=<a href='/topic/show?id=32e765e6591' target=_blank style='color:#2F92EE;'>#消化道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65765, encryptionId=32e765e6591, topicName=消化道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b6e6676048, createdName=changhe715, createdTime=Thu Aug 22 01:36:00 CST 2019, time=2019-08-22, status=1, ipAttribution=)]
    2019-10-26 amyloid
  2. [GetPortalCommentsPageByObjectIdResponse(id=1775471, encodeId=a3081e7547169, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Sat Oct 26 20:36:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723078, encodeId=56331e2307821, content=<a href='/topic/show?id=0cc01998259' target=_blank style='color:#2F92EE;'>#上消化道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19982, encryptionId=0cc01998259, topicName=上消化道)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b81833366357, createdName=zchen, createdTime=Sat Jan 11 23:36:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946557, encodeId=d365194655e9b, content=<a href='/topic/show?id=91c646562f6' target=_blank style='color:#2F92EE;'>#富士胶片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46562, encryptionId=91c646562f6, topicName=富士胶片)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Wed Feb 19 22:36:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799694, encodeId=1a231e9969490, content=<a href='/topic/show?id=85b9e10284e' target=_blank style='color:#2F92EE;'>#病理对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71028, encryptionId=85b9e10284e, topicName=病理对照)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Wed Aug 21 20:36:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464626, encodeId=3bad146462658, content=<a href='/topic/show?id=32e765e6591' target=_blank style='color:#2F92EE;'>#消化道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65765, encryptionId=32e765e6591, topicName=消化道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b6e6676048, createdName=changhe715, createdTime=Thu Aug 22 01:36:00 CST 2019, time=2019-08-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1775471, encodeId=a3081e7547169, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Sat Oct 26 20:36:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723078, encodeId=56331e2307821, content=<a href='/topic/show?id=0cc01998259' target=_blank style='color:#2F92EE;'>#上消化道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19982, encryptionId=0cc01998259, topicName=上消化道)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b81833366357, createdName=zchen, createdTime=Sat Jan 11 23:36:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946557, encodeId=d365194655e9b, content=<a href='/topic/show?id=91c646562f6' target=_blank style='color:#2F92EE;'>#富士胶片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46562, encryptionId=91c646562f6, topicName=富士胶片)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Wed Feb 19 22:36:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799694, encodeId=1a231e9969490, content=<a href='/topic/show?id=85b9e10284e' target=_blank style='color:#2F92EE;'>#病理对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71028, encryptionId=85b9e10284e, topicName=病理对照)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Wed Aug 21 20:36:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464626, encodeId=3bad146462658, content=<a href='/topic/show?id=32e765e6591' target=_blank style='color:#2F92EE;'>#消化道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65765, encryptionId=32e765e6591, topicName=消化道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b6e6676048, createdName=changhe715, createdTime=Thu Aug 22 01:36:00 CST 2019, time=2019-08-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1775471, encodeId=a3081e7547169, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Sat Oct 26 20:36:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723078, encodeId=56331e2307821, content=<a href='/topic/show?id=0cc01998259' target=_blank style='color:#2F92EE;'>#上消化道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19982, encryptionId=0cc01998259, topicName=上消化道)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b81833366357, createdName=zchen, createdTime=Sat Jan 11 23:36:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946557, encodeId=d365194655e9b, content=<a href='/topic/show?id=91c646562f6' target=_blank style='color:#2F92EE;'>#富士胶片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46562, encryptionId=91c646562f6, topicName=富士胶片)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Wed Feb 19 22:36:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799694, encodeId=1a231e9969490, content=<a href='/topic/show?id=85b9e10284e' target=_blank style='color:#2F92EE;'>#病理对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71028, encryptionId=85b9e10284e, topicName=病理对照)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Wed Aug 21 20:36:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464626, encodeId=3bad146462658, content=<a href='/topic/show?id=32e765e6591' target=_blank style='color:#2F92EE;'>#消化道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65765, encryptionId=32e765e6591, topicName=消化道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b6e6676048, createdName=changhe715, createdTime=Thu Aug 22 01:36:00 CST 2019, time=2019-08-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1775471, encodeId=a3081e7547169, content=<a href='/topic/show?id=937d46650bf' target=_blank style='color:#2F92EE;'>#对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46650, encryptionId=937d46650bf, topicName=对照)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae138776909, createdName=amyloid, createdTime=Sat Oct 26 20:36:00 CST 2019, time=2019-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1723078, encodeId=56331e2307821, content=<a href='/topic/show?id=0cc01998259' target=_blank style='color:#2F92EE;'>#上消化道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19982, encryptionId=0cc01998259, topicName=上消化道)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b81833366357, createdName=zchen, createdTime=Sat Jan 11 23:36:00 CST 2020, time=2020-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1946557, encodeId=d365194655e9b, content=<a href='/topic/show?id=91c646562f6' target=_blank style='color:#2F92EE;'>#富士胶片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46562, encryptionId=91c646562f6, topicName=富士胶片)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc4b2500077, createdName=hittouch, createdTime=Wed Feb 19 22:36:00 CST 2020, time=2020-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799694, encodeId=1a231e9969490, content=<a href='/topic/show?id=85b9e10284e' target=_blank style='color:#2F92EE;'>#病理对照#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71028, encryptionId=85b9e10284e, topicName=病理对照)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3516494, createdName=spoonycyy, createdTime=Wed Aug 21 20:36:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464626, encodeId=3bad146462658, content=<a href='/topic/show?id=32e765e6591' target=_blank style='color:#2F92EE;'>#消化道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65765, encryptionId=32e765e6591, topicName=消化道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b6e6676048, createdName=changhe715, createdTime=Thu Aug 22 01:36:00 CST 2019, time=2019-08-22, status=1, ipAttribution=)]

相关资讯

假如中国生物医药产业“被断供”……

谷歌、ARM、高通、陶氏……在供应链高度专业化和全球化的今天,没有坚实的“备胎计划”,一系列供应商接二连三的“釜底抽薪”,对任何一家下游企业的打击显然是致命的。 曾有智者说过,“中国制造业落后就要挨打,中国科研落后就要被卡脖子”。正激流勇进的生物医药行业,倘若也来一次极限假设遭遇“断供”,是否也能像华为那样云淡风轻呢?小编只是一个外行,在此抛砖引玉吧。

数字化是破解生物医药产业园区发展瓶颈的“对症之药”

当前生物技术正掀起新一轮产业革命的浪潮,生物产业与信息、材料、能源等产业加速融合。全球生物医药产业每5年翻一番,是世界经济增长率的10倍,正成为重塑全球经济版图的变革力量。

我国生物医药产业发展领先城市政策导向

通过梳理我国生物医药产业发展领先城市出台的相关生物医药产业促进政策,本文主要研究其政策导向和策略,从政策层面总结先进城市促进产业发展的领先经验,对其他地区制定产业政策具有一定借鉴意义。 一、国内重点城市生物医药产业发展促进政策对比研究

原创新药加速赛跑,生物医药创制的上海进行时

中国的新药的研制,一直是我们国家重大战略的需求,也是我们国家重要的研究计划。加强原创新药的研发,是中国从医药大国向医药强国发展的必由之路。 5月24日,由上海市科协、新民晚报和中国科学院上海药物研究所联合主办的新民科学咖啡馆上海科技节特别专场在上海科学会堂成功举办。会议特邀中国科学院院士、中国科学院上海药物研究所研究员蒋华良和上海市药品监督管理局副局长张清作报告,聚焦生物医药创制的上海进

数字化促进生物医药产业区域协同发展

随着国内生物医药产业持续快速增长,区域协同成为未来产业升级和高质量发展的关键因素。区域协同发展包括城市集群之间、城市之间及同一城市区县园区之间不同层级。基于数字化开展面向区域协同的顶层规划和产业组织,统筹产业资源,提高产业发展效能是区域协同发展的有效路径。

重磅!艾昆纬西部运营总部落户成都高新区

成都高新区良好的生物医药产业发展环境吸引世界知名企业纷纷入驻,距世界500强吉利德科学西部运营中心入驻仅一周时间,成都高新区又迎来全球最大医疗研究服务公司艾昆纬西部运营总部。7月16日,成都高新区生物产业生态圈发展对话会暨成都高新区生物产业(天府国际生物城)推介活动在上海举行,艾昆纬中国中西部首个投资项目——艾昆纬西部运营总部签约落户成都高新区,将建设国际领先、中国中西部首个全球顶尖CRO企业直接